GGrantIndex
← Leaderboards

Andria Lee Ford

Washington University

$9,289,709
Attributed
$17,243,058
Total exposure
5
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.4M · FY201125
$5M$3.8M$2.5M$1.3M$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,243,058 · 5

By mechanism

UF1$6,224,729 · 1
R01$5,895,398 · 1
RF1$3,443,971 · 1
K23$872,424 · 1
U24$806,536 · 1

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Others in their field

Top investigators on “Stroke

Research focus

StrokeMagnetic Resonance ImagingCerebrumOxygenTissuesInfarctionMetabolismDisabilityCerebrovascular CirculationGrantMetabolicBrain TissueFutureHigh RiskFollow-UpAdultBiological MarkersImpaired CognitionChildhoodChronicLeadBloodMetabolic StressSickle Cell Anemia

Grant awards (21)

Mid-America Regional Coordinating Center (MARCC)$380,171
U24 · FY2025 · NS
MR-Derived Cerebral Oxygen Metabolism underlying Ischemic Vulnerability in Sickle Cell Disease$651,816
R01 · FY2024 · HL · contact PI
Mid-America Regional Coordinating Center (MARCC)$426,365
U24 · FY2024 · NS
Washington University University of Texas Southwestern VCID Consortium Site$3,689,604
UF1 · FY2023 · NS
MR-Derived Cerebral Oxygen Metabolism underlying Ischemic Vulnerability in Sickle Cell Disease$670,529
R01 · FY2023 · HL · contact PI
MR-Derived Cerebral Oxygen Metabolism underlying Ischemic Vulnerability in Sickle Cell Disease$673,931
R01 · FY2022 · HL · contact PI
Washington University University of Texas Southwestern VCID Consortium Site$2,535,125
UF1 · FY2021 · NS
MR-Derived Cerebral Oxygen Metabolism underlying Ischemic Vulnerability in Sickle Cell Disease$676,397
R01 · FY2021 · HL · contact PI
MR measured regional hypoxia as an early biomarker in cerebral small vessel disease$3,443,971
RF1 · FY2020 · NS
MR-Derived Cerebral Oxygen Metabolism underlying Ischemic Vulnerability in Sickle Cell Disease$683,879
R01 · FY2020 · HL · contact PI
MR-Derived Cerebral Blood Flow and Oxygen Metabolism to Stratify Stroke Risk in Pediatric Sickle Cell Disease$437,712
R01 · FY2019 · HL · contact PI
MR-Derived Cerebral Blood Flow and Oxygen Metabolism to Stratify Stroke Risk in Pediatric Sickle Cell Disease$19,843
R01 · FY2019 · HL · contact PI
MR-Derived Cerebral Blood Flow and Oxygen Metabolism to Stratify Stroke Risk in Pediatric Sickle Cell Disease$479,694
R01 · FY2018 · HL · contact PI
MR-Derived Cerebral Blood Flow and Oxygen Metabolism to Stratify Stroke Risk in Pediatric Sickle Cell Disease$508,470
R01 · FY2017 · HL · contact PI
MR-Derived Cerebral Blood Flow and Oxygen Metabolism to Stratify Stroke Risk in Pediatric Sickle Cell Disease$534,896
R01 · FY2016 · HL · contact PI
MR-Derived Cerebral Blood Flow and Oxygen Metabolism to Stratify Stroke Risk in Pediatric Sickle Cell Disease$558,231
R01 · FY2015 · HL · contact PI
DEFINING THE ISCHEMIC PENUMBRA WITH MAGNETIC RESONANCE OXYGEN METABOLISM$177,076
K23 · FY2015 · NS · contact PI
DEFINING THE ISCHEMIC PENUMBRA WITH MAGNETIC RESONANCE OXYGEN METABOLISM$177,076
K23 · FY2014 · NS · contact PI
DEFINING THE ISCHEMIC PENUMBRA WITH MAGNETIC RESONANCE OXYGEN METABOLISM$177,076
K23 · FY2013 · NS · contact PI
DEFINING THE ISCHEMIC PENUMBRA WITH MAGNETIC RESONANCE OXYGEN METABOLISM$177,076
K23 · FY2012 · NS · contact PI
DEFINING THE ISCHEMIC PENUMBRA WITH MAGNETIC RESONANCE OXYGEN METABOLISM$164,120
K23 · FY2011 · NS · contact PI